11.International Drug Conference, Antalya, Türkiye, 9 - 12 Mart 2023, sa.8356575, ss.61-65
Breast cancer, which is the second most common cancer among women [1], has been a
prominent health challenge worldwide. Thus, more studies are necessitated on this subject.
Hence, this study aims to examine the Spectroscopic Properties, Molecular Docking, and
Density Functional Theory (DFT) calculations of the new vicinal dioxime compound, LH2,
containing thiosemicarbazone, and its Cobalt(II) complex, in order to investigate if they can be
used as a chemotherapeutic medication for the treatment of breast cancer.
In the study, first of all, anti-chloroglyoxime and then novel vicinal compound bearing
thiosemicarbazone side groups N-((1E,2E)-1,2-bis(hydroxyimino)ethyl)-2-(2-hydroxy-4-
methoxybenzylidene)hydrazinecarbothioamide,) were synthesized. The ligand afforded the
corresponding thiosemicarbazone-based vicinal dioxime. Transition metal complex of this
ligand was complexed with divalent Cobalt(II) chloride salt to yield the complex: Co(LH)2. New
compounds were characterized by a combination of 1H and 13C Nuclear Magnetic Resonance
(NMR), Fourier Transform-Infrared Spectroscopy (FTIR), Elemental Analysis and Magnetic
Susceptibility measurements. The effects of varying pH and solvent on the absorption
behavior of both ligand and Co(LH)2 complex have been investigated. Furthermore, Molecular
Docking studies were performed against two different target proteins (PDB IDs: 2IOK, 2A91).
The docking results of two different proteins (2IOK, 2A91) with Co(LH)2 showed higher binding
affinities, when compared to LH2. The self-dockings were also performed with the own ligands
of the target proteins in order to validate the accuracy of the method. Moreover, the Frontier
Molecular Orbitals (FMOs) were obtained by using DFT at 6–311++G (d, p) for the investigation
of the molecular structural properties. From DFT calculations, Co(LH)2 was observed to have
good electrophile ability.
In conclusion, the results indicated that, especially the Co(LH)2 has a good chemotherapeutic
potential for the treatment of breast cancer.